PENTASA PROLONGED RELEASE GRANULES 2G/SACHET [SIN14456P]
Active ingredients: PENTASA PROLONGED RELEASE GRANULES 2G/SACHET
Last updated 24 April 2026
Product Info
PENTASA PROLONGED RELEASE GRANULES 2G/SACHET
[SIN14456P]
Product information
Active Ingredient and Strength | MESALAZINE - 2,000 MG |
Dosage Form | GRANULE, DELAYED RELEASE |
Manufacturer and Country | FERRING INTERNATIONAL CENTER SA - SWITZERLAND |
Registration Number | SIN14456P |
Licence Holder | FERRING PHARMACEUTICALS PRIVATE LIMITED |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | A07EC02 |
Prescription-only Medicines with Exemptions for Supply without Prescription | NA |
Indication
THERAPEUTIC INDICATIONS
Treatment of mild to moderate ulcerative colitis.
Dosing
POSOLOGY AND METHOD OF ADMINISTRATION
Posology:
Ulcerative colitis
Treatment of active disease:
Adults: Individual dosage, up to 4 g given once daily or in divided doses.
Paediatric population:
There is only limited documentation for an effect in children (age 6–18 years).
Method of administration:
PENTASA® granules must not be chewed. The contents of the sachet should be emptied onto the tongue and washed down with some water or orange juice. Alternatively the entire content of the sachet can be taken with yogurt and consumed immediately.
Contraindications
CONTRAINDICATIONS
Hypersensitivity to mesalazine, any of the excipients, or salicylates.
Severe liver or renal impairment.